Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ear zap may turbocharge athlete recovery

NCT ID NCT06281795

Symptom relief Sponsor: Bakulev Scientific Center of Cardiovascular Surgery Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial tests whether a gentle electrical stimulation of the vagus nerve through the ear (tVNS) can help athletes recover more quickly after intense training. About 121 professional athletes in sports like swimming, athletics, and gymnastics will use the device daily for 60 minutes after workouts over 8 weeks. Researchers will measure changes in oxygen use, heart rate, and fatigue levels to see if the treatment speeds recovery and reduces muscle soreness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous vagus nerve stimulation (tVNS) device applied to the ear
What this could lead to
If it works, this could offer athletes a drug-free way to speed up recovery, reduce fatigue, and improve performance.
What could go wrong
This is a small, early-stage trial in a specific group of athletes, so results may not apply to everyone. The effect may be modest or not statistically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

121 people

The number who actually took part.

Started

Apr 2024

Finished

Mar 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Professional athletes over the age of 15 and under the age of 35; * Cyclic sports (swimming, modern pentathlon, athletics, triathlon); * Difficult coordination sports (dance sports, rhythmic gymnastics); * Sports category: no lower than candidate for master of sports; * Voluntary informed consent. Exclusion Criteria: * Atypical and unrelated to physical exertion changes on the ECG (T wave inversion, st-segment depression, pathological Q waves, signs of left atrial enlargement, signs of right ventricular hypertrophy, ventricular pre-excitation, complete right or left bundle branch block, prolonged or shortened Q-T interval, Brugada-like early repolarization); * Heart rhythm and conduction disorders (frequent ventricular and supraventricular extrasystoles, first-degree atrioventricular block (P-Q \> 0.21 s, not shortened during hyperventilation or physical exertion), second or third degree); * Expressed sinus bradycardia with resting heart rate \< 40 bpm; * Taking glucocorticosteroids in the last 1 month; * Taking any antiarrhythmic drugs, including beta-blockers.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Efficacy, self are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

combat disorder Fatigue Mental Fatigue

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Efficacy, self Fatigue, mental Fatigue; combat Fatigue; muscle, heart

Contacts and locations

Locations

  • Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPION

    Krasnodar, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.